amlodipine has been researched along with Cardiovascular Pregnancy Complications in 7 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methyldopa and amlodipine are associated with the least side effects in pregnant women treated for chronic hypertension." | 7.96 | The comparison of side effects of methyldopa, amlodipine, and metoprolol in pregnant women with chronic hypertension. ( Ghafarzadeh, M; Namdari, P; Shakarami, A; Yari, F, 2020) |
| "Background Amlodipine is used for the treatment of hypertension, but reports on its use in early pregnancy are limited." | 7.91 | Safety of Amlodipine in Early Pregnancy. ( Arata, N; Ito, S; Kamiya, CA; Mikami, M; Mito, A; Miyasato-Isoda, M; Murashima, A; Suzuki, T; Wada, Y; Waguri, M; Watanabe, O; Yakuwa, N; Yoshimatsu, J, 2019) |
| " The incidence of severe hypertension was significantly lower when nifedipine (odds ratio, 0." | 5.05 | Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. ( Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V, 2020) |
| "Methyldopa and amlodipine are associated with the least side effects in pregnant women treated for chronic hypertension." | 3.96 | The comparison of side effects of methyldopa, amlodipine, and metoprolol in pregnant women with chronic hypertension. ( Ghafarzadeh, M; Namdari, P; Shakarami, A; Yari, F, 2020) |
| "Background Amlodipine is used for the treatment of hypertension, but reports on its use in early pregnancy are limited." | 3.91 | Safety of Amlodipine in Early Pregnancy. ( Arata, N; Ito, S; Kamiya, CA; Mikami, M; Mito, A; Miyasato-Isoda, M; Murashima, A; Suzuki, T; Wada, Y; Waguri, M; Watanabe, O; Yakuwa, N; Yoshimatsu, J, 2019) |
| " This study aims to investigate whether calcium channel blockers plus low dosage aspirin therapy can reduce the incidence of complications during pregnancy with chronic hypertension and improve the prognosis of neonates." | 3.81 | The effect of calcium channel blockers on prevention of preeclampsia in pregnant women with chronic hypertension. ( Jiang, N; Liu, L; Liu, Q; Yang, WW; Zeng, Y, 2015) |
| "Subcutaneous fat necrosis of the newborn (SCFN) is a relatively uncommon condition of the skin which is said to be benign and painless." | 1.30 | Painful subcutaneous fat necrosis of the newborn associated with intra-partum use of a calcium channel blocker. ( Haque, KN; Holden, CA; Johnson, A; Rosbotham, JL, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Taguchi, R | 1 |
| Naito, T | 1 |
| Kubono, N | 1 |
| Ogawa, N | 1 |
| Itoh, H | 1 |
| Kawakami, J | 1 |
| Bellos, I | 1 |
| Pergialiotis, V | 1 |
| Papapanagiotou, A | 1 |
| Loutradis, D | 1 |
| Daskalakis, G | 1 |
| Ghafarzadeh, M | 1 |
| Shakarami, A | 1 |
| Yari, F | 1 |
| Namdari, P | 1 |
| Mito, A | 1 |
| Murashima, A | 1 |
| Wada, Y | 1 |
| Miyasato-Isoda, M | 1 |
| Kamiya, CA | 1 |
| Waguri, M | 1 |
| Yoshimatsu, J | 1 |
| Yakuwa, N | 1 |
| Watanabe, O | 1 |
| Suzuki, T | 1 |
| Arata, N | 1 |
| Mikami, M | 1 |
| Ito, S | 1 |
| Jiang, N | 1 |
| Liu, Q | 1 |
| Liu, L | 1 |
| Yang, WW | 1 |
| Zeng, Y | 1 |
| Davidovich, IM | 1 |
| Bloshchinskaia, IA | 1 |
| Petrichko, TA | 1 |
| Rosbotham, JL | 1 |
| Johnson, A | 1 |
| Haque, KN | 1 |
| Holden, CA | 1 |
1 review available for amlodipine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease | 2020 |
6 other studies available for amlodipine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Relationships between endogenous CYP3A markers and plasma amlodipine exposure and metabolism in early postpartum and non-peripartum women with hypertension.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Biomarker | 2019 |
The comparison of side effects of methyldopa, amlodipine, and metoprolol in pregnant women with chronic hypertension.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Incidence; | 2020 |
Safety of Amlodipine in Early Pregnancy.
Topics: Abnormalities, Drug-Induced; Aged; Amlodipine; Antihypertensive Agents; Chronic Disease; Female; Fol | 2019 |
The effect of calcium channel blockers on prevention of preeclampsia in pregnant women with chronic hypertension.
Topics: Adult; Amlodipine; Aspirin; Birth Weight; Blood Pressure; Calcium Channel Blockers; China; Female; H | 2015 |
[Gestational arterial hypertension. Mechanisms of formation. Treatment with normodipin].
Topics: Adolescent; Adult; Amlodipine; Antihypertensive Agents; Arm; Arteries; Blood Flow Velocity; Endothel | 2003 |
Painful subcutaneous fat necrosis of the newborn associated with intra-partum use of a calcium channel blocker.
Topics: Amlodipine; Calcium Channel Blockers; Fat Necrosis; Female; Humans; Hypertension; Infant, Newborn; M | 1998 |